Pentamed® - High performance packaging films for medical devices

AMA Releases CPT III Code for iCometrix's AI-Based Brain MRI Quantification Software

Saturday, July 01, 2023

The American Medical Association (AMA) has recently issued a dedicated Current Procedural Terminology (CPT) code for icometrix's brain MRI quantification software. This software utilizes artificial intelligence (AI) and has received FDA clearance. The issuance of the CPT code allows for potential reimbursement and creates a pathway for hospitals and imaging centers to submit claims for the AI-based analysis of brain MRI scans provided by icometrix.

icometrix is a leading AI company specializing in brain imaging. Their software offers clinically relevant metrics for cerebral MRI scans, providing quantitative analysis and AI insights that assist clinicians in diagnosing, monitoring, and assessing treatment response for various brain disorders including multiple sclerosis, Alzheimer's disease, dementia, epilepsy, traumatic brain injury, and stroke.

The utilization of CPT codes by Medicare, Medicaid, and commercial health plans in the United States helps identify healthcare procedures and services. With the new CPT code in place, healthcare facilities can now seek reimbursement for the AI-driven analysis of brain MRI scans performed using icometrix's software.

The recognition of icometrix's technology through the issuance of a CPT code marks a significant advancement in the integration of innovative AI solutions in the management of brain disorders. This development brings us closer to a future where precision medicine guides treatment decisions for conditions such as multiple sclerosis. The quantitative analysis provided by icometrix's software, alongside radiological readings, supports data-driven clinical decision-making in the field of neurology.

The demand for brain MRI procedures is increasing due to shifting demographics and aging populations, leading to a growing burden of neurologic diseases. The need for accurate biomarkers to assess and manage these conditions is essential. The complexity of neuroimaging tasks continues to rise, making the integration of AI technology even more valuable. As technology advances and new treatments emerge, including those for stroke, traumatic brain injury, and neurodegenerative diseases like Alzheimer's, the importance of quantitative imaging and assessment of brain MRI scans is expected to grow rapidly.



Healthcare CEO & Executive Strategy SummitNational Healthcare CMO Summit USANational Healthcare CNO Summit USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitACO Leadership Summit